aiqbench analysis
This article introduces CoDHy, an AI system designed to function as a co-scientist for generating and validating drug combination hypotheses in oncology using biomarker data. By integrating knowledge graphs with agent-based reasoning, the tool allows researchers to iteratively refine evidence-grounded hypotheses while maintaining control over prioritization. This represents a significant advancement in applying machine learning agents to accelerate translational research workflows.
From Literature to Hypotheses: An AI Co-Scientist System for Biomarker-Guided Drug Combination Hypothesis Generation
arXiv:2603.00612v2 Announce Type: replace Abstract: The rapid growth of biomedical evidence makes it difficult to translate biomarker mechanisms into actionable drug combination hypotheses. We present CoDHy, an interactive AI co-scientist for biomarker-guided hypothesis generation in oncology. CoDHy constructs task-specific knowledge graphs from curated databases and biomedical literature, then combines graph embeddings with agent-based reasoning to generate, validate, and rank evidence-grounded drug combinations. Through a web interface, researchers specify the biomarker, cancer context, and literature scope; inspect supporting evidence and intermediate results; and iteratively refine the generated hypotheses. The demonstration presents CoDHy's end-to-end workflow and shows how researchers can interactively explore and compare mechanistically supported drug combinations while remaining in control of hypothesis prioritization.
Abstract:The rapid growth of biomedical evidence makes it difficult to translate biomarker mechanisms into actionable drug combination hypotheses. We present CoDHy, an interactive AI co-scientist for biomarker-guided hypothesis generation in oncology. CoDHy constructs task-specific knowledge graphs from curated databases and biomedical literature, then combines graph embeddings with agent-based reasoning to generate, validate, and rank evidence-grounded drug combinations. Through a web interface, researchers specify the biomarker, cancer context, and literature scope; inspect supporting evidence and intermediate results; and iteratively refine the generated hypotheses. The demonstration presents CoDHy's end-to-end workflow and shows how researchers can interactively explore and compare mechanistically supported drug combinations while remaining in control of hypothesis prioritization.
Computation and Language (cs.CL)
arXiv:2603.00612 [cs.CL]
(or arXiv:2603.00612v2 [cs.CL] for this version)
https://doi.org/10.48550/arXiv.2603.00612 Focus to learn more arXiv-issued DOI via DataCite
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 201 words
Related coverage
Introducing Quine: An AI research system designed for the complexity of biology
Microsoft Research · Sep 29, 2026
The Continual Constitutional Convention: How language models revise the documents that govern them
AI Alignment Forum · Oct 13, 2026

An AI tool for prioritizing candidate biomarkers from wearable sensor data
Google Research · Aug 21, 2026
Co-Scientist: A multi-agent AI partner to accelerate research
Google DeepMind · May 12, 2026